[Influence of the treatment on humoral immunity in toxoplasmosis].
D000917:Antibody Formation / Q000187:drug effects; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007933:Leucomycins / Q000008:administration & dosage; D008297:Male; D011739:Pyrimethamine / Q000008:administration & dosage; D012008:Recurrence; D013411:Sulfadiazine / Q000008:administration & dosage; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy* / Q000276:immunology
D007933:Leucomycins; D013411:Sulfadiazine; D011739:Pyrimethamine
Influence du traitement sur l'immunité humorale dans la toxoplasmose.